YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Heart growth is tightly controlled so that the heart reaches a predetermined size. Fetal heart growth occurs through cardiomyocyte proliferation, whereas postnatal heart growth involves primarily physiological cardiomyocyte hypertrophy. The Hippo kinase cascade is an important regulator of organ growth. A major target of this kinase cascade is YAP1, a transcriptional coactivator that is inactivated by Hippo kinase activity. Here, we used both genetic gain and loss of Yap1 function to investigate its role in regulating proliferative and physiologic hypertrophic heart growth. Fetal Yap1 inactivation caused marked, lethal myocardial hypoplasia and decreased cardiomyocyte proliferation, whereas fetal activation of YAP1 stimulated cardiomyocyte proliferation. Enhanced proliferation was particularly dramatic in trabecular cardiomyocytes that normally exit from the cell cycle. Remarkably, YAP1 activation was sufficient to stimulate proliferation of postnatal cardiomyocytes, both in culture and in the intact heart. A dominant negative peptide that blocked YAP1 binding to TEAD transcription factors inhibited YAP1 proliferative activity, indicating that this activity requires YAP1–TEAD interaction. Although Yap1 was a critical regulator of cardiomyocyte proliferation, it did not influence physiological hypertrophic growth of cardiomyocytes, because postnatal Yap1 gain or loss of function did not significantly alter cardiomyocyte size. These studies demonstrate that Yap1 is a crucial regulator of cardiomyocyte proliferation, cardiac morphogenesis, and myocardial trabeculation. Activation of Yap1 in postnatal cardiomyocytes may be a useful strategy to stimulate cardiomyocyte expansion in therapeutic myocardial regeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, two other teams reported no cardiomyocyte hypertrophy upon Yap activation in postnatal mouse hearts in vivo (139, 154).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [139]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491 · cited 9×
“In these embryos, Tnnt2–Cre activated membrane-localized GFP (mGFP) from the Cre-activated Rosa26mTmG reporter and inactivated the conditional Yap1 allele specifically in cardiomyocytes.”
BackgroundInfluentialZhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 1×
“We developed an adenoviral vector to express activated YAP1 with an N-terminal triple FLAG epitope (Ad:FLAG–aYap1), where “activated YAP1” contained a serine 127 to alanine substitution that blocked Hippo pathway-mediated YAP1 inactivation (18).”
MethodElucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Requirement for neuregulin receptor erbB2 in neural and cardiac development
Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,290
Multiple essential functions of neuregulin in development
Meyer, D., & Birchmeier, C. (1995) · Nature · doi:10.1038/378386a0 · Cited by 1,262
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252 · cited 2×
“TetO-YAP1 (10), Yap1 (11), Yap1 (11), Rosa26 (15), Rosa26 (33), and Tnnt2-Cre (13) alleles were described.”
BackgroundSelf-citationWu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., & Martin, J. F. (2011) · Science · doi:10.1126/science.1199010 · Cited by 1,092
DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1
Jerome, L. A., & Papaioannou, V. E. (2001) · Nature Genetics · doi:10.1038/85845 · Cited by 1,084
Hippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
Self-citationThe Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis
Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 976
Rapid Transition of Cardiac Myocytes from Hyperplasia to Hypertrophy During Postnatal Development
Li, F. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0163 · Cited by 833
Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y., & DePamphilis, M. L. (2001) · Genes & Development · doi:10.1101/gad.888601 · Cited by 719 · cited 1×
“To assess the role of YAP1–TEAD interactions in promoting cardiomyocyte proliferation, we expressed GFP fused to a region of YAP1 sufficient to bind TEAD (25).”
BackgroundWu, S., Liu, Y., Zheng, Y., Dong, J., & Pan, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.007 · Cited by 640
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control
Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., & Jiang, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.006 · Cited by 630 · cited 1×
“In the absence of phosphorylation by the Hpo kinases cascade, Yki coactivates transcription in conjunction with specific transcription factors, such as the TEAD family transcription factor Scalloped (Sd), stimulating organ growth by increasing cell proliferation and reducing apoptosis (8, 9).”
BackgroundControl of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats
Lai, Z.-C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L.-L., & Li, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.036 · Cited by 568
The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila
Pantalacci, S., Tapon, N., & Léopold, P. (2003) · Nature Cell Biology · doi:10.1038/ncb1051 · Cited by 551
The Hippo–YAP pathway: new connections between regulation of organ size and cancer
Zhao, B., Lei, Q.-Y., & Guan, K.-L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.001 · Cited by 455
Belteki, G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni051 · Cited by 378
An essential role of Bmp4 in the atrioventricular septation of the mouse heart
Jiao, K., Kulessa, H., Tompkins, K., Zhou, Y., Batts, L., Baldwin, H. S., & Hogan, B. L. M. (2003) · Genes & Development · doi:10.1101/gad.1124803 · Cited by 366 · cited 13×
“In these embryos, Tnnt2–Cre activated membrane-localized GFP (mGFP) from the Cre-activated Rosa26mTmG reporter and inactivated the conditional Yap1 allele specifically in cardiomyocytes.”
BackgroundInfluentialPasumarthi, K. B. S., Nakajima, H., Nakajima, H. O., Soonpaa, M. H., & Field, L. J. (2005) · Circulation Research · doi:10.1161/01.res.0000152326.91223.4f · Cited by 344
Yamamoto, S., Yang, G., Zablocki, D., Liu, J., Hong, C., Kim, S.-J., Soler, S., Odashima, M., Thaisz, J., Yehia, G., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17459 · Cited by 278
Soonpaa, M. H., Koh, G. Y., Pajak, L., Jing, S., Wang, H., Franklin, M. T., Kim, K. K., & Field, L. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119453 · Cited by 253
A dual role for ErbB2 signaling in cardiac trabeculation
Liu, J., Bressan, M., Hassel, D., Huisken, J., Staudt, D., Kikuchi, K., Poss, K. D., Mikawa, T., & Stainier, D. Y. R. (2010) · Development · doi:10.1242/dev.053736 · Cited by 250
Cyclin A2 Mediates Cardiomyocyte Mitosis in the Postmitotic Myocardium
Chaudhry, H. W., Dashoush, N. H., Tang, H., Zhang, L., Wang, X., Wu, E. X., & Wolgemuth, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404975200 · Cited by 214
Bisping, E., Ikeda, S., Kong, S. W., Tarnavski, O., Bodyak, N., McMullen, J. R., Rajagopal, S., Son, J. K., Ma, Q., Springer, Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602543103 · Cited by 185
Self-citationLats2 Is a Negative Regulator of Myocyte Size in the Heart
Matsui, Y., Nakano, N., Shao, D., Gao, S., Luo, W., Hong, C., Zhai, P., Holle, E., Yu, X., Yabuta, N., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.180042 · Cited by 131
Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction and Prevents Heart Failure
Cheng, R. K., Asai, T., Tang, H., Dashoush, N. H., Kara, R. J., Costa, K. D., Naka, Y., Wu, E. X., Wolgemuth, D. J., & Chaudhry, H. W. (2007) · Circulation Research · doi:10.1161/circresaha.107.153544 · Cited by 126
Forced expression of the cyclin B1–CDC2 complex induces proliferation in adult rat cardiomyocytes
Bicknell, K. A., Coxon, C. H., & Brooks, G. (2004) · Biochemical Journal · doi:10.1042/bj20031481 · Cited by 94
Ishiwata, T., Nakazawa, M., Pu, W. T., Tevosian, S. G., & Izumo, S. (2003) · Circulation Research · doi:10.1161/01.res.0000100389.57520.1a · Cited by 88
Self-citationThe DeMSTification of Mammalian Ste20 Kinases
Radu, M., & Chernoff, J. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.022 · Cited by 76
Wang, G., Yeh, H. I., & Lin, J. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43855-0 · Cited by 49
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
The Hippo Pathway: Biology and Pathophysiology
Ma, S., Meng, Z., Chen, R., & Guan, K.-L. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111829 · Cited by 1,387
“Deletion of Sav1 in the mouse heart causes elevated cardiomyocyte proliferation in the developing as well as postnatal stages (190, 191).”
BackgroundThe Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Metadata
- Authors
- von Gise, A., Lin, Z., Schlegelmilch, K., Honor, L. B., Pan, G. M., Buck, J. N., Ma, Q., Ishiwata, T., Zhou, B., Camargo, F. D., & Pu, W. T.
- Affiliations
- Department of Cardiology and
- Boston Children's Hospital (US)
- University of Utah (US)
- Chinese Academy of Sciences (CN)
- Harvard Stem Cell Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-01-30
- Volume
- 109
- Issue
- 7
- Pages
- 2394-2399
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3289361
- OpenAlex
- W2009682316
- Cited by
- 573
- References
- 35
- Citations by year
- 2026: 20 · 2025: 39 · 2024: 47 · 2023: 41 · 2022: 49 · 2021: 57 · 2020: 59 · 2019: 41 · 2018: 42 · 2017: 35 · 2016: 34 · 2015: 32 · 2014: 43 · 2013: 29 · 2012: 4
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01hl100401-07)
- National Heart, Lung, and Blood Institute (HL100401, U01-HL-100401, HL095712, R01HL095712)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- YAP, Hippo signaling pathway, cardiac growth, cardiomyocyte proliferation, cardiomyocyte hypertrophy, cardiac morphogenesis, cardiac regeneration, postnatal heart development
- MeSH terms
- Serine-Threonine Kinase 3, YAP-Signaling Proteins, Hippo Kinases, Animals, Heart, Cardiomegaly, Myocardium, Signal Transduction, Protein Serine-Threonine Kinases, Genes, cdc, Apoptosis Regulatory Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.